Skip to main content

LLS Podcast

Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join The Patient Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.

Listen to The Bloodline with LLS

To subscribe to The Bloodline with LLS, click here.

Recent Episodes

How to Address Physical, Emotional and Cognitive Challenges of Cancer with Palliative Care

Join us as we speak to Dr. Areej El-Jawahri, a physician researcher at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School. In this episode, Dr. El-Jawahri shares the wonderful benefits of palliative care for both blood cancer patients and their families. Often erroneously associated with hospice or end of life care, palliative care can be started at any point after diagnosis and has shown many benefits with being started early in treatment. In palliative care, the physical, emotional and cognitive challenges after a cancer diagnosis are addressed by a specialized team of providers, leading to a more comfortable experience through treatment and beyond.

Support for this episode provided by Bristol Myers Squibb; Genentech, Inc. & Biogen; Pharmacyclics LLC, An AbbVie Company & Janssen Biotech, Inc.

Hope for Rare Cancers: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Join us as we speak to Dr. Eunice Wang, the Chief of Leukemia Service and Professor of Oncology at Roswell Park Comprehensive Cancer Center in Buffalo, NY. In this episode, Dr. Wang delves into the rare blood cancer, blastic plasmacytoid dendritic cell neoplasm (BPDCN). Usually identified by characteristic deep purple lesions, oncologists continue to raise awareness of this rare diagnosis, as swift referral and treatment usually leads to better outcomes. After being universally identified as BPDCN by World Health Organization (WHO) in 2018, clinical trials and CAR T-cell therapies have brought new hope to BPDCN patients.

Support for this episode provided by ImmunoGen.

Patient-Doctor Perspectives: Groundbreaking Research in CML

Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a patient and doctor. To celebrate the 100th episode of The Bloodline with LLS, we will be speaking with Mel Mann, a chronic myeloid leukemia (CML) survivor and Dr. Brian Druker, a physician researcher at Oregon Health Sciences University (OHSU). 

Mel shares how Dr. Druker’s research saved his life with the drug, Gleevec®, and we get to hear his inspirational message of how one person can make a difference. Dr. Druker discusses this revolutionary therapy, how it transformed the lives of CML patients like Mel, and how targeted treatments are continuing to transform how we treat cancer. 

Support for this episode provided by Pfizer.

Listen to The Bloodline with LLS

Support for The Bloodline with LLS provided by Amgen; AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Kite, A Gilead Company; Novartis; Pharmacyclics, an AbbVie company and Janssen Biotech; Seattle Genetics and Takeda Oncology.

*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.

To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.